Jamaica vs Marshall Islands: Previously treated cases tested for RR-/MDR-TB
Jamaica
100.0%
in 2023
Marshall Islands
100.0%
in 2024
Jamaica rank
1st
Marshall Islands rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Jamaica
- Marshall Islands
How they compare
Jamaica currently reports 100.0% against 100.0% in Marshall Islands, a difference of 0.0%.
The two have swapped places 8 times across 12 shared years of data; in 2005 it was Marshall Islands ahead.
Jamaica ranks 1st and Marshall Islands ranks 1st of 180 countries.
Marshall Islands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jamaica | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.0% | 38.5% | 8.5% | Marshall Islands |
| 2010s | 43.7% | 45.4% | 1.8% | Marshall Islands |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Jamaica or Marshall Islands?
- Jamaica, at 100.0% against 100.0% in Marshall Islands as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Jamaica and Marshall Islands?
- 0.0%, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and Marshall Islands?
- 12 years are reported by both, from 2005 to 2023.
- How do Jamaica and Marshall Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Jamaica ranks 1st and Marshall Islands ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.